# Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma

> **NCT01965834** · PHASE2 · TERMINATED · sponsor: **University of Miami** · enrollment: 6 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Fenofibrate

## Key facts

- **NCT ID:** NCT01965834
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-11-19
- **Primary completion:** 2016-03-21
- **Final completion:** 2016-07-01
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Lack of adequate accrual.
- **Last updated:** 2017-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01965834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01965834, "Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01965834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*